nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HRH1—atherosclerosis	0.355	1	CbGaD
Aripiprazole—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0282	0.0807	CbGbCtD
Aripiprazole—CYP3A7—Simvastatin—atherosclerosis	0.0282	0.0807	CbGbCtD
Aripiprazole—CYP3A7—Lovastatin—atherosclerosis	0.0276	0.079	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0276	0.079	CbGbCtD
Aripiprazole—CYP3A5—Rosuvastatin—atherosclerosis	0.0227	0.0651	CbGbCtD
Aripiprazole—CYP3A5—Simvastatin—atherosclerosis	0.0211	0.0606	CbGbCtD
Aripiprazole—CYP3A5—Lovastatin—atherosclerosis	0.0207	0.0593	CbGbCtD
Aripiprazole—CYP3A5—Pravastatin—atherosclerosis	0.0207	0.0593	CbGbCtD
Aripiprazole—CYP2D6—Niacin—atherosclerosis	0.0164	0.047	CbGbCtD
Aripiprazole—ABCB1—Ezetimibe—atherosclerosis	0.0148	0.0424	CbGbCtD
Aripiprazole—ABCB1—Simvastatin—atherosclerosis	0.0138	0.0394	CbGbCtD
Aripiprazole—ABCB1—Pravastatin—atherosclerosis	0.0135	0.0386	CbGbCtD
Aripiprazole—ABCB1—Lovastatin—atherosclerosis	0.0135	0.0386	CbGbCtD
Aripiprazole—CYP2D6—Simvastatin—atherosclerosis	0.013	0.0371	CbGbCtD
Aripiprazole—CYP2D6—Pravastatin—atherosclerosis	0.0127	0.0363	CbGbCtD
Aripiprazole—CYP2D6—Lovastatin—atherosclerosis	0.0127	0.0363	CbGbCtD
Aripiprazole—CYP3A4—Ezetimibe—atherosclerosis	0.00887	0.0254	CbGbCtD
Aripiprazole—CYP3A4—Rosuvastatin—atherosclerosis	0.00887	0.0254	CbGbCtD
Aripiprazole—CYP3A4—Simvastatin—atherosclerosis	0.00825	0.0236	CbGbCtD
Aripiprazole—CYP3A4—Pravastatin—atherosclerosis	0.00807	0.0231	CbGbCtD
Aripiprazole—CYP3A4—Lovastatin—atherosclerosis	0.00807	0.0231	CbGbCtD
Aripiprazole—HTR2A—arteriole—atherosclerosis	0.00217	0.0836	CbGeAlD
Aripiprazole—HTR7—vein—atherosclerosis	0.00208	0.0799	CbGeAlD
Aripiprazole—HTR2A—vein—atherosclerosis	0.0013	0.0498	CbGeAlD
Aripiprazole—HTR1B—artery—atherosclerosis	0.0011	0.0422	CbGeAlD
Aripiprazole—HTR1D—artery—atherosclerosis	0.00106	0.0409	CbGeAlD
Aripiprazole—HTR2A—hindlimb—atherosclerosis	0.000861	0.0331	CbGeAlD
Aripiprazole—HTR1B—blood vessel—atherosclerosis	0.000855	0.0329	CbGeAlD
Aripiprazole—Ziprasidone—HRH1—atherosclerosis	0.000853	0.336	CrCbGaD
Aripiprazole—HTR7—artery—atherosclerosis	0.000846	0.0326	CbGeAlD
Aripiprazole—HTR1D—blood vessel—atherosclerosis	0.000828	0.0318	CbGeAlD
Aripiprazole—HTR2A—appendage—atherosclerosis	0.000739	0.0284	CbGeAlD
Aripiprazole—HTR7—endothelium—atherosclerosis	0.000715	0.0275	CbGeAlD
Aripiprazole—Trazodone—HRH1—atherosclerosis	0.000664	0.262	CrCbGaD
Aripiprazole—HTR7—blood vessel—atherosclerosis	0.000659	0.0254	CbGeAlD
Aripiprazole—Prochlorperazine—HRH1—atherosclerosis	0.000594	0.234	CrCbGaD
Aripiprazole—H1F0—connective tissue—atherosclerosis	0.000548	0.0211	CbGeAlD
Aripiprazole—HTR2A—artery—atherosclerosis	0.000528	0.0203	CbGeAlD
Aripiprazole—H1F0—cardiovascular system—atherosclerosis	0.000477	0.0183	CbGeAlD
Aripiprazole—HTR2A—endothelium—atherosclerosis	0.000446	0.0172	CbGeAlD
Aripiprazole—Perphenazine—HRH1—atherosclerosis	0.000425	0.168	CrCbGaD
Aripiprazole—HTR1D—connective tissue—atherosclerosis	0.000424	0.0163	CbGeAlD
Aripiprazole—H1F0—adipose tissue—atherosclerosis	0.00042	0.0162	CbGeAlD
Aripiprazole—ADRB1—connective tissue—atherosclerosis	0.000412	0.0159	CbGeAlD
Aripiprazole—HTR2A—blood vessel—atherosclerosis	0.000411	0.0158	CbGeAlD
Aripiprazole—CYP3A7—liver—atherosclerosis	0.000398	0.0153	CbGeAlD
Aripiprazole—HTR1B—cardiovascular system—atherosclerosis	0.000381	0.0147	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—atherosclerosis	0.000379	0.0146	CbGeAlD
Aripiprazole—HTR1D—cardiovascular system—atherosclerosis	0.000369	0.0142	CbGeAlD
Aripiprazole—ADRB1—cardiovascular system—atherosclerosis	0.000359	0.0138	CbGeAlD
Aripiprazole—CHRM1—cardiovascular system—atherosclerosis	0.000345	0.0133	CbGeAlD
Aripiprazole—HTR2B—cardiovascular system—atherosclerosis	0.000343	0.0132	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000338	0.013	CbGeAlD
Aripiprazole—HTR7—connective tissue—atherosclerosis	0.000338	0.013	CbGeAlD
Aripiprazole—ADRB1—adipose tissue—atherosclerosis	0.000316	0.0122	CbGeAlD
Aripiprazole—HTR1A—cardiovascular system—atherosclerosis	0.000308	0.0118	CbGeAlD
Aripiprazole—HTR2B—adipose tissue—atherosclerosis	0.000303	0.0117	CbGeAlD
Aripiprazole—H1F0—liver—atherosclerosis	0.000295	0.0113	CbGeAlD
Aripiprazole—HTR7—cardiovascular system—atherosclerosis	0.000294	0.0113	CbGeAlD
Aripiprazole—ADRA1A—cardiovascular system—atherosclerosis	0.000284	0.0109	CbGeAlD
Aripiprazole—KCNH2—cardiovascular system—atherosclerosis	0.000274	0.0105	CbGeAlD
Aripiprazole—CHRM3—adipose tissue—atherosclerosis	0.000272	0.0105	CbGeAlD
Aripiprazole—ABCB1—blood vessel—atherosclerosis	0.000269	0.0104	CbGeAlD
Aripiprazole—HRH1—connective tissue—atherosclerosis	0.000252	0.00971	CbGeAlD
Aripiprazole—ADRA1A—adipose tissue—atherosclerosis	0.00025	0.00962	CbGeAlD
Aripiprazole—ADRA2A—connective tissue—atherosclerosis	0.000248	0.00954	CbGeAlD
Aripiprazole—ADRA2C—adipose tissue—atherosclerosis	0.000238	0.00917	CbGeAlD
Aripiprazole—HTR2A—connective tissue—atherosclerosis	0.000211	0.00811	CbGeAlD
Aripiprazole—CYP3A5—adipose tissue—atherosclerosis	0.0002	0.00768	CbGeAlD
Aripiprazole—HRH1—adipose tissue—atherosclerosis	0.000194	0.00745	CbGeAlD
Aripiprazole—ADRA2A—adipose tissue—atherosclerosis	0.00019	0.00732	CbGeAlD
Aripiprazole—HTR2A—cardiovascular system—atherosclerosis	0.000183	0.00706	CbGeAlD
Aripiprazole—HTR7—liver—atherosclerosis	0.000182	0.007	CbGeAlD
Aripiprazole—ADRA1A—liver—atherosclerosis	0.000175	0.00675	CbGeAlD
Aripiprazole—ADRA2C—liver—atherosclerosis	0.000167	0.00643	CbGeAlD
Aripiprazole—Flushing—Pravastatin—atherosclerosis	0.000156	0.001	CcSEcCtD
Aripiprazole—Cardiac disorder—Pravastatin—atherosclerosis	0.000156	0.001	CcSEcCtD
Aripiprazole—Muscle spasms—Simvastatin—atherosclerosis	0.000156	0.000999	CcSEcCtD
Aripiprazole—Vertigo—Lovastatin—atherosclerosis	0.000156	0.000998	CcSEcCtD
Aripiprazole—Angioedema—Ezetimibe—atherosclerosis	0.000155	0.000995	CcSEcCtD
Aripiprazole—Angiopathy—Niacin—atherosclerosis	0.000155	0.000994	CcSEcCtD
Aripiprazole—Leukopenia—Lovastatin—atherosclerosis	0.000155	0.000994	CcSEcCtD
Aripiprazole—Chills—Niacin—atherosclerosis	0.000153	0.000983	CcSEcCtD
Aripiprazole—Malaise—Ezetimibe—atherosclerosis	0.000153	0.000982	CcSEcCtD
Aripiprazole—Vision blurred—Simvastatin—atherosclerosis	0.000153	0.000979	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000152	0.000974	CcSEcCtD
Aripiprazole—Tremor—Simvastatin—atherosclerosis	0.000152	0.000973	CcSEcCtD
Aripiprazole—Alopecia—Niacin—atherosclerosis	0.000151	0.000968	CcSEcCtD
Aripiprazole—Chills—Pravastatin—atherosclerosis	0.000151	0.000968	CcSEcCtD
Aripiprazole—Insomnia—Rosuvastatin—atherosclerosis	0.000151	0.000967	CcSEcCtD
Aripiprazole—Ill-defined disorder—Simvastatin—atherosclerosis	0.00015	0.000964	CcSEcCtD
Aripiprazole—Palpitations—Ezetimibe—atherosclerosis	0.00015	0.000962	CcSEcCtD
Aripiprazole—Paraesthesia—Rosuvastatin—atherosclerosis	0.00015	0.00096	CcSEcCtD
Aripiprazole—Anaemia—Simvastatin—atherosclerosis	0.00015	0.00096	CcSEcCtD
Aripiprazole—Malnutrition—Niacin—atherosclerosis	0.000149	0.000954	CcSEcCtD
Aripiprazole—Erythema—Niacin—atherosclerosis	0.000149	0.000954	CcSEcCtD
Aripiprazole—Alopecia—Pravastatin—atherosclerosis	0.000149	0.000953	CcSEcCtD
Aripiprazole—Cough—Ezetimibe—atherosclerosis	0.000148	0.00095	CcSEcCtD
Aripiprazole—Angioedema—Simvastatin—atherosclerosis	0.000148	0.000949	CcSEcCtD
Aripiprazole—Chest pain—Lovastatin—atherosclerosis	0.000147	0.000945	CcSEcCtD
Aripiprazole—Arthralgia—Lovastatin—atherosclerosis	0.000147	0.000945	CcSEcCtD
Aripiprazole—Myalgia—Lovastatin—atherosclerosis	0.000147	0.000945	CcSEcCtD
Aripiprazole—Anxiety—Lovastatin—atherosclerosis	0.000147	0.000942	CcSEcCtD
Aripiprazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000147	0.000941	CcSEcCtD
Aripiprazole—Hypertension—Ezetimibe—atherosclerosis	0.000147	0.00094	CcSEcCtD
Aripiprazole—Flatulence—Niacin—atherosclerosis	0.000147	0.00094	CcSEcCtD
Aripiprazole—Malaise—Simvastatin—atherosclerosis	0.000146	0.000937	CcSEcCtD
Aripiprazole—Tension—Niacin—atherosclerosis	0.000146	0.000936	CcSEcCtD
Aripiprazole—Discomfort—Lovastatin—atherosclerosis	0.000146	0.000934	CcSEcCtD
Aripiprazole—Vertigo—Simvastatin—atherosclerosis	0.000146	0.000933	CcSEcCtD
Aripiprazole—Leukopenia—Simvastatin—atherosclerosis	0.000145	0.00093	CcSEcCtD
Aripiprazole—Chest pain—Ezetimibe—atherosclerosis	0.000145	0.000927	CcSEcCtD
Aripiprazole—Myalgia—Ezetimibe—atherosclerosis	0.000145	0.000927	CcSEcCtD
Aripiprazole—Arthralgia—Ezetimibe—atherosclerosis	0.000145	0.000927	CcSEcCtD
Aripiprazole—Nervousness—Niacin—atherosclerosis	0.000144	0.000926	CcSEcCtD
Aripiprazole—Flatulence—Pravastatin—atherosclerosis	0.000144	0.000925	CcSEcCtD
Aripiprazole—Dry mouth—Lovastatin—atherosclerosis	0.000144	0.000925	CcSEcCtD
Aripiprazole—Tension—Pravastatin—atherosclerosis	0.000144	0.000921	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000144	0.000921	CcSEcCtD
Aripiprazole—Dysgeusia—Pravastatin—atherosclerosis	0.000143	0.00092	CcSEcCtD
Aripiprazole—Muscle spasms—Niacin—atherosclerosis	0.000143	0.000917	CcSEcCtD
Aripiprazole—Discomfort—Ezetimibe—atherosclerosis	0.000143	0.000916	CcSEcCtD
Aripiprazole—Pain—Rosuvastatin—atherosclerosis	0.000143	0.000914	CcSEcCtD
Aripiprazole—Constipation—Rosuvastatin—atherosclerosis	0.000143	0.000914	CcSEcCtD
Aripiprazole—Confusional state—Lovastatin—atherosclerosis	0.000142	0.000914	CcSEcCtD
Aripiprazole—Nervousness—Pravastatin—atherosclerosis	0.000142	0.000912	CcSEcCtD
Aripiprazole—Dry mouth—Ezetimibe—atherosclerosis	0.000141	0.000907	CcSEcCtD
Aripiprazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000141	0.000906	CcSEcCtD
Aripiprazole—Muscle spasms—Pravastatin—atherosclerosis	0.000141	0.000903	CcSEcCtD
Aripiprazole—Infection—Lovastatin—atherosclerosis	0.00014	0.0009	CcSEcCtD
Aripiprazole—Vision blurred—Niacin—atherosclerosis	0.00014	0.000899	CcSEcCtD
Aripiprazole—CYP3A5—liver—atherosclerosis	0.00014	0.00538	CbGeAlD
Aripiprazole—Confusional state—Ezetimibe—atherosclerosis	0.00014	0.000896	CcSEcCtD
Aripiprazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000139	0.000889	CcSEcCtD
Aripiprazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000138	0.000887	CcSEcCtD
Aripiprazole—Vision blurred—Pravastatin—atherosclerosis	0.000138	0.000885	CcSEcCtD
Aripiprazole—Chest pain—Simvastatin—atherosclerosis	0.000138	0.000884	CcSEcCtD
Aripiprazole—Arthralgia—Simvastatin—atherosclerosis	0.000138	0.000884	CcSEcCtD
Aripiprazole—Myalgia—Simvastatin—atherosclerosis	0.000138	0.000884	CcSEcCtD
Aripiprazole—Infection—Ezetimibe—atherosclerosis	0.000138	0.000883	CcSEcCtD
Aripiprazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000137	0.000881	CcSEcCtD
Aripiprazole—Anxiety—Simvastatin—atherosclerosis	0.000137	0.000881	CcSEcCtD
Aripiprazole—Tremor—Pravastatin—atherosclerosis	0.000137	0.00088	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000136	0.000874	CcSEcCtD
Aripiprazole—Discomfort—Simvastatin—atherosclerosis	0.000136	0.000874	CcSEcCtD
Aripiprazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000136	0.000872	CcSEcCtD
Aripiprazole—Angioedema—Niacin—atherosclerosis	0.000136	0.000871	CcSEcCtD
Aripiprazole—Ill-defined disorder—Pravastatin—atherosclerosis	0.000136	0.000871	CcSEcCtD
Aripiprazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000136	0.00087	CcSEcCtD
Aripiprazole—Anaemia—Pravastatin—atherosclerosis	0.000135	0.000868	CcSEcCtD
Aripiprazole—Anorexia—Lovastatin—atherosclerosis	0.000135	0.000864	CcSEcCtD
Aripiprazole—Skin disorder—Ezetimibe—atherosclerosis	0.000135	0.000863	CcSEcCtD
Aripiprazole—Angioedema—Pravastatin—atherosclerosis	0.000134	0.000858	CcSEcCtD
Aripiprazole—Vertigo—Niacin—atherosclerosis	0.000134	0.000857	CcSEcCtD
Aripiprazole—Syncope—Niacin—atherosclerosis	0.000133	0.000855	CcSEcCtD
Aripiprazole—Confusional state—Simvastatin—atherosclerosis	0.000133	0.000855	CcSEcCtD
Aripiprazole—Leukopenia—Niacin—atherosclerosis	0.000133	0.000854	CcSEcCtD
Aripiprazole—Urticaria—Rosuvastatin—atherosclerosis	0.000132	0.00085	CcSEcCtD
Aripiprazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000132	0.000848	CcSEcCtD
Aripiprazole—Oedema—Simvastatin—atherosclerosis	0.000132	0.000848	CcSEcCtD
Aripiprazole—Malaise—Pravastatin—atherosclerosis	0.000132	0.000847	CcSEcCtD
Aripiprazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000132	0.000845	CcSEcCtD
Aripiprazole—Vertigo—Pravastatin—atherosclerosis	0.000132	0.000844	CcSEcCtD
Aripiprazole—Palpitations—Niacin—atherosclerosis	0.000131	0.000843	CcSEcCtD
Aripiprazole—Infection—Simvastatin—atherosclerosis	0.000131	0.000842	CcSEcCtD
Aripiprazole—Leukopenia—Pravastatin—atherosclerosis	0.000131	0.000841	CcSEcCtD
Aripiprazole—Loss of consciousness—Niacin—atherosclerosis	0.000131	0.000838	CcSEcCtD
Aripiprazole—Cough—Niacin—atherosclerosis	0.00013	0.000832	CcSEcCtD
Aripiprazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.000129	0.00083	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000129	0.000826	CcSEcCtD
Aripiprazole—Insomnia—Lovastatin—atherosclerosis	0.000128	0.00082	CcSEcCtD
Aripiprazole—Cough—Pravastatin—atherosclerosis	0.000128	0.000819	CcSEcCtD
Aripiprazole—Paraesthesia—Lovastatin—atherosclerosis	0.000127	0.000814	CcSEcCtD
Aripiprazole—Myalgia—Niacin—atherosclerosis	0.000127	0.000812	CcSEcCtD
Aripiprazole—Arthralgia—Niacin—atherosclerosis	0.000127	0.000812	CcSEcCtD
Aripiprazole—Hypertension—Pravastatin—atherosclerosis	0.000126	0.000811	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000126	0.00081	CcSEcCtD
Aripiprazole—Anorexia—Simvastatin—atherosclerosis	0.000126	0.000808	CcSEcCtD
Aripiprazole—Dyspnoea—Lovastatin—atherosclerosis	0.000126	0.000808	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000126	0.000806	CcSEcCtD
Aripiprazole—Insomnia—Ezetimibe—atherosclerosis	0.000125	0.000804	CcSEcCtD
Aripiprazole—Chest pain—Pravastatin—atherosclerosis	0.000125	0.000799	CcSEcCtD
Aripiprazole—Arthralgia—Pravastatin—atherosclerosis	0.000125	0.000799	CcSEcCtD
Aripiprazole—Myalgia—Pravastatin—atherosclerosis	0.000125	0.000799	CcSEcCtD
Aripiprazole—Paraesthesia—Ezetimibe—atherosclerosis	0.000124	0.000798	CcSEcCtD
Aripiprazole—Dyspepsia—Lovastatin—atherosclerosis	0.000124	0.000798	CcSEcCtD
Aripiprazole—Anxiety—Pravastatin—atherosclerosis	0.000124	0.000797	CcSEcCtD
Aripiprazole—Dry mouth—Niacin—atherosclerosis	0.000124	0.000794	CcSEcCtD
Aripiprazole—Dyspnoea—Ezetimibe—atherosclerosis	0.000124	0.000792	CcSEcCtD
Aripiprazole—Discomfort—Pravastatin—atherosclerosis	0.000123	0.00079	CcSEcCtD
Aripiprazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000123	0.000788	CcSEcCtD
Aripiprazole—Decreased appetite—Lovastatin—atherosclerosis	0.000123	0.000788	CcSEcCtD
Aripiprazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000122	0.000782	CcSEcCtD
Aripiprazole—Fatigue—Lovastatin—atherosclerosis	0.000122	0.000781	CcSEcCtD
Aripiprazole—Oedema—Niacin—atherosclerosis	0.000121	0.000778	CcSEcCtD
Aripiprazole—Anaphylactic shock—Niacin—atherosclerosis	0.000121	0.000778	CcSEcCtD
Aripiprazole—Pain—Lovastatin—atherosclerosis	0.000121	0.000775	CcSEcCtD
Aripiprazole—Constipation—Lovastatin—atherosclerosis	0.000121	0.000775	CcSEcCtD
Aripiprazole—Confusional state—Pravastatin—atherosclerosis	0.000121	0.000773	CcSEcCtD
Aripiprazole—Decreased appetite—Ezetimibe—atherosclerosis	0.00012	0.000773	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00012	0.000772	CcSEcCtD
Aripiprazole—ABCB1—cardiovascular system—atherosclerosis	0.00012	0.00462	CbGeAlD
Aripiprazole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00012	0.000767	CcSEcCtD
Aripiprazole—Asthenia—Rosuvastatin—atherosclerosis	0.00012	0.000767	CcSEcCtD
Aripiprazole—Insomnia—Simvastatin—atherosclerosis	0.00012	0.000767	CcSEcCtD
Aripiprazole—Oedema—Pravastatin—atherosclerosis	0.00012	0.000766	CcSEcCtD
Aripiprazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.00012	0.000766	CcSEcCtD
Aripiprazole—Fatigue—Ezetimibe—atherosclerosis	0.00012	0.000766	CcSEcCtD
Aripiprazole—Shock—Niacin—atherosclerosis	0.000119	0.000766	CcSEcCtD
Aripiprazole—Infection—Pravastatin—atherosclerosis	0.000119	0.000761	CcSEcCtD
Aripiprazole—Paraesthesia—Simvastatin—atherosclerosis	0.000119	0.000761	CcSEcCtD
Aripiprazole—Constipation—Ezetimibe—atherosclerosis	0.000119	0.00076	CcSEcCtD
Aripiprazole—Pain—Ezetimibe—atherosclerosis	0.000119	0.00076	CcSEcCtD
Aripiprazole—Tachycardia—Niacin—atherosclerosis	0.000118	0.00076	CcSEcCtD
Aripiprazole—Pruritus—Rosuvastatin—atherosclerosis	0.000118	0.000757	CcSEcCtD
Aripiprazole—Skin disorder—Niacin—atherosclerosis	0.000118	0.000756	CcSEcCtD
Aripiprazole—Dyspnoea—Simvastatin—atherosclerosis	0.000118	0.000756	CcSEcCtD
Aripiprazole—Hyperhidrosis—Niacin—atherosclerosis	0.000117	0.000752	CcSEcCtD
Aripiprazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000117	0.00075	CcSEcCtD
Aripiprazole—Feeling abnormal—Lovastatin—atherosclerosis	0.000116	0.000747	CcSEcCtD
Aripiprazole—Dyspepsia—Simvastatin—atherosclerosis	0.000116	0.000746	CcSEcCtD
Aripiprazole—Anorexia—Niacin—atherosclerosis	0.000116	0.000742	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000116	0.000741	CcSEcCtD
Aripiprazole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000116	0.000741	CcSEcCtD
Aripiprazole—Decreased appetite—Simvastatin—atherosclerosis	0.000115	0.000737	CcSEcCtD
Aripiprazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000114	0.000732	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000114	0.000732	CcSEcCtD
Aripiprazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000114	0.000732	CcSEcCtD
Aripiprazole—Fatigue—Simvastatin—atherosclerosis	0.000114	0.000731	CcSEcCtD
Aripiprazole—Anorexia—Pravastatin—atherosclerosis	0.000114	0.000731	CcSEcCtD
Aripiprazole—Hypotension—Niacin—atherosclerosis	0.000113	0.000727	CcSEcCtD
Aripiprazole—HTR2A—liver—atherosclerosis	0.000113	0.00436	CbGeAlD
Aripiprazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000113	0.000727	CcSEcCtD
Aripiprazole—Pain—Simvastatin—atherosclerosis	0.000113	0.000725	CcSEcCtD
Aripiprazole—Constipation—Simvastatin—atherosclerosis	0.000113	0.000725	CcSEcCtD
Aripiprazole—Urticaria—Lovastatin—atherosclerosis	0.000112	0.00072	CcSEcCtD
Aripiprazole—Body temperature increased—Lovastatin—atherosclerosis	0.000112	0.000716	CcSEcCtD
Aripiprazole—Abdominal pain—Lovastatin—atherosclerosis	0.000112	0.000716	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000111	0.000709	CcSEcCtD
Aripiprazole—Dizziness—Rosuvastatin—atherosclerosis	0.00011	0.000707	CcSEcCtD
Aripiprazole—Urticaria—Ezetimibe—atherosclerosis	0.00011	0.000706	CcSEcCtD
Aripiprazole—Insomnia—Niacin—atherosclerosis	0.00011	0.000704	CcSEcCtD
Aripiprazole—Body temperature increased—Ezetimibe—atherosclerosis	0.00011	0.000703	CcSEcCtD
Aripiprazole—Abdominal pain—Ezetimibe—atherosclerosis	0.00011	0.000703	CcSEcCtD
Aripiprazole—Paraesthesia—Niacin—atherosclerosis	0.000109	0.000699	CcSEcCtD
Aripiprazole—Feeling abnormal—Simvastatin—atherosclerosis	0.000109	0.000699	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000109	0.000698	CcSEcCtD
Aripiprazole—Dyspnoea—Niacin—atherosclerosis	0.000108	0.000694	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000108	0.000693	CcSEcCtD
Aripiprazole—Insomnia—Pravastatin—atherosclerosis	0.000108	0.000693	CcSEcCtD
Aripiprazole—Somnolence—Niacin—atherosclerosis	0.000108	0.000692	CcSEcCtD
Aripiprazole—Paraesthesia—Pravastatin—atherosclerosis	0.000107	0.000688	CcSEcCtD
Aripiprazole—Dyspepsia—Niacin—atherosclerosis	0.000107	0.000685	CcSEcCtD
Aripiprazole—Dyspnoea—Pravastatin—atherosclerosis	0.000107	0.000683	CcSEcCtD
Aripiprazole—ABCB1—adipose tissue—atherosclerosis	0.000106	0.00408	CbGeAlD
Aripiprazole—Decreased appetite—Niacin—atherosclerosis	0.000106	0.000677	CcSEcCtD
Aripiprazole—Dyspepsia—Pravastatin—atherosclerosis	0.000105	0.000675	CcSEcCtD
Aripiprazole—Rash—Rosuvastatin—atherosclerosis	0.000105	0.000674	CcSEcCtD
Aripiprazole—Dermatitis—Rosuvastatin—atherosclerosis	0.000105	0.000674	CcSEcCtD
Aripiprazole—Urticaria—Simvastatin—atherosclerosis	0.000105	0.000673	CcSEcCtD
Aripiprazole—CYP3A4—liver—atherosclerosis	0.000105	0.00404	CbGeAlD
Aripiprazole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000105	0.000672	CcSEcCtD
Aripiprazole—Abdominal pain—Simvastatin—atherosclerosis	0.000104	0.00067	CcSEcCtD
Aripiprazole—Body temperature increased—Simvastatin—atherosclerosis	0.000104	0.00067	CcSEcCtD
Aripiprazole—Headache—Rosuvastatin—atherosclerosis	0.000104	0.00067	CcSEcCtD
Aripiprazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000104	0.000668	CcSEcCtD
Aripiprazole—Decreased appetite—Pravastatin—atherosclerosis	0.000104	0.000666	CcSEcCtD
Aripiprazole—Pain—Niacin—atherosclerosis	0.000104	0.000666	CcSEcCtD
Aripiprazole—CYP2D6—liver—atherosclerosis	0.000103	0.00398	CbGeAlD
Aripiprazole—Fatigue—Pravastatin—atherosclerosis	0.000103	0.000661	CcSEcCtD
Aripiprazole—Constipation—Pravastatin—atherosclerosis	0.000102	0.000655	CcSEcCtD
Aripiprazole—Pain—Pravastatin—atherosclerosis	0.000102	0.000655	CcSEcCtD
Aripiprazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000102	0.000655	CcSEcCtD
Aripiprazole—Asthenia—Lovastatin—atherosclerosis	0.000101	0.00065	CcSEcCtD
Aripiprazole—Pruritus—Lovastatin—atherosclerosis	0.0001	0.000641	CcSEcCtD
Aripiprazole—Asthenia—Ezetimibe—atherosclerosis	9.95e-05	0.000638	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Niacin—atherosclerosis	9.93e-05	0.000636	CcSEcCtD
Aripiprazole—Nausea—Rosuvastatin—atherosclerosis	9.91e-05	0.000635	CcSEcCtD
Aripiprazole—Feeling abnormal—Pravastatin—atherosclerosis	9.85e-05	0.000632	CcSEcCtD
Aripiprazole—Pruritus—Ezetimibe—atherosclerosis	9.81e-05	0.000629	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Pravastatin—atherosclerosis	9.77e-05	0.000627	CcSEcCtD
Aripiprazole—Hypersensitivity—Simvastatin—atherosclerosis	9.74e-05	0.000625	CcSEcCtD
Aripiprazole—Diarrhoea—Lovastatin—atherosclerosis	9.67e-05	0.00062	CcSEcCtD
Aripiprazole—Urticaria—Niacin—atherosclerosis	9.64e-05	0.000618	CcSEcCtD
Aripiprazole—Abdominal pain—Niacin—atherosclerosis	9.6e-05	0.000615	CcSEcCtD
Aripiprazole—Body temperature increased—Niacin—atherosclerosis	9.6e-05	0.000615	CcSEcCtD
Aripiprazole—Urticaria—Pravastatin—atherosclerosis	9.49e-05	0.000609	CcSEcCtD
Aripiprazole—Asthenia—Simvastatin—atherosclerosis	9.48e-05	0.000608	CcSEcCtD
Aripiprazole—Diarrhoea—Ezetimibe—atherosclerosis	9.48e-05	0.000608	CcSEcCtD
Aripiprazole—Body temperature increased—Pravastatin—atherosclerosis	9.45e-05	0.000606	CcSEcCtD
Aripiprazole—Abdominal pain—Pravastatin—atherosclerosis	9.45e-05	0.000606	CcSEcCtD
Aripiprazole—Pruritus—Simvastatin—atherosclerosis	9.35e-05	0.0006	CcSEcCtD
Aripiprazole—Dizziness—Lovastatin—atherosclerosis	9.35e-05	0.000599	CcSEcCtD
Aripiprazole—Dizziness—Ezetimibe—atherosclerosis	9.17e-05	0.000588	CcSEcCtD
Aripiprazole—Diarrhoea—Simvastatin—atherosclerosis	9.04e-05	0.00058	CcSEcCtD
Aripiprazole—Vomiting—Lovastatin—atherosclerosis	8.99e-05	0.000576	CcSEcCtD
Aripiprazole—Hypersensitivity—Niacin—atherosclerosis	8.94e-05	0.000573	CcSEcCtD
Aripiprazole—Rash—Lovastatin—atherosclerosis	8.91e-05	0.000571	CcSEcCtD
Aripiprazole—Dermatitis—Lovastatin—atherosclerosis	8.9e-05	0.000571	CcSEcCtD
Aripiprazole—Headache—Lovastatin—atherosclerosis	8.85e-05	0.000568	CcSEcCtD
Aripiprazole—Vomiting—Ezetimibe—atherosclerosis	8.81e-05	0.000565	CcSEcCtD
Aripiprazole—Hypersensitivity—Pravastatin—atherosclerosis	8.8e-05	0.000565	CcSEcCtD
Aripiprazole—Dizziness—Simvastatin—atherosclerosis	8.74e-05	0.000561	CcSEcCtD
Aripiprazole—Rash—Ezetimibe—atherosclerosis	8.74e-05	0.00056	CcSEcCtD
Aripiprazole—Dermatitis—Ezetimibe—atherosclerosis	8.73e-05	0.00056	CcSEcCtD
Aripiprazole—Asthenia—Niacin—atherosclerosis	8.71e-05	0.000558	CcSEcCtD
Aripiprazole—Headache—Ezetimibe—atherosclerosis	8.68e-05	0.000557	CcSEcCtD
Aripiprazole—Pruritus—Niacin—atherosclerosis	8.59e-05	0.000551	CcSEcCtD
Aripiprazole—Asthenia—Pravastatin—atherosclerosis	8.57e-05	0.00055	CcSEcCtD
Aripiprazole—Pruritus—Pravastatin—atherosclerosis	8.46e-05	0.000542	CcSEcCtD
Aripiprazole—Vomiting—Simvastatin—atherosclerosis	8.4e-05	0.000539	CcSEcCtD
Aripiprazole—Nausea—Lovastatin—atherosclerosis	8.39e-05	0.000538	CcSEcCtD
Aripiprazole—Rash—Simvastatin—atherosclerosis	8.33e-05	0.000534	CcSEcCtD
Aripiprazole—Dermatitis—Simvastatin—atherosclerosis	8.33e-05	0.000534	CcSEcCtD
Aripiprazole—Diarrhoea—Niacin—atherosclerosis	8.3e-05	0.000533	CcSEcCtD
Aripiprazole—Headache—Simvastatin—atherosclerosis	8.28e-05	0.000531	CcSEcCtD
Aripiprazole—Nausea—Ezetimibe—atherosclerosis	8.23e-05	0.000528	CcSEcCtD
Aripiprazole—Diarrhoea—Pravastatin—atherosclerosis	8.18e-05	0.000524	CcSEcCtD
Aripiprazole—Dizziness—Niacin—atherosclerosis	8.03e-05	0.000515	CcSEcCtD
Aripiprazole—Dizziness—Pravastatin—atherosclerosis	7.9e-05	0.000507	CcSEcCtD
Aripiprazole—Nausea—Simvastatin—atherosclerosis	7.85e-05	0.000504	CcSEcCtD
Aripiprazole—Vomiting—Niacin—atherosclerosis	7.72e-05	0.000495	CcSEcCtD
Aripiprazole—Rash—Niacin—atherosclerosis	7.65e-05	0.000491	CcSEcCtD
Aripiprazole—Dermatitis—Niacin—atherosclerosis	7.65e-05	0.00049	CcSEcCtD
Aripiprazole—Headache—Niacin—atherosclerosis	7.6e-05	0.000488	CcSEcCtD
Aripiprazole—Vomiting—Pravastatin—atherosclerosis	7.6e-05	0.000487	CcSEcCtD
Aripiprazole—Rash—Pravastatin—atherosclerosis	7.54e-05	0.000483	CcSEcCtD
Aripiprazole—Dermatitis—Pravastatin—atherosclerosis	7.53e-05	0.000483	CcSEcCtD
Aripiprazole—Headache—Pravastatin—atherosclerosis	7.49e-05	0.00048	CcSEcCtD
Aripiprazole—ABCB1—liver—atherosclerosis	7.43e-05	0.00286	CbGeAlD
Aripiprazole—Nausea—Niacin—atherosclerosis	7.21e-05	0.000462	CcSEcCtD
Aripiprazole—Nausea—Pravastatin—atherosclerosis	7.1e-05	0.000455	CcSEcCtD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—atherosclerosis	2.2e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	2.2e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	2.19e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—atherosclerosis	2.19e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—atherosclerosis	2.19e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—atherosclerosis	2.18e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AGT—atherosclerosis	2.18e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	2.17e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	2.17e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	2.16e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—STAT3—atherosclerosis	2.16e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	2.16e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—atherosclerosis	2.15e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.15e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	2.14e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—STAT3—atherosclerosis	2.13e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—atherosclerosis	2.13e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	2.13e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.13e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	2.13e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	2.13e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	2.12e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.12e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CAV1—atherosclerosis	2.11e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	2.11e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOA1—atherosclerosis	2.11e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	2.1e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	2.1e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—AKT1—atherosclerosis	2.1e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.09e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.09e-06	1.88e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.08e-06	1.87e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.07e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK3—atherosclerosis	2.07e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.06e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.05e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.05e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.04e-06	1.84e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK3—atherosclerosis	2.04e-06	1.84e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.03e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.03e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.03e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.02e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.02e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2.02e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—atherosclerosis	2e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CXCL8—atherosclerosis	1.99e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	1.99e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	1.99e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	1.98e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—atherosclerosis	1.98e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.97e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—atherosclerosis	1.97e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	1.97e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.96e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	1.96e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	1.96e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.96e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.96e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	1.95e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.94e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.94e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—atherosclerosis	1.93e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.93e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.93e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	1.93e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	1.93e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	1.93e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.92e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.92e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	1.91e-06	1.72e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—atherosclerosis	1.9e-06	1.71e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—atherosclerosis	1.9e-06	1.71e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	1.89e-06	1.71e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.89e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—atherosclerosis	1.89e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—atherosclerosis	1.88e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.88e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.87e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—atherosclerosis	1.87e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.86e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.86e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.86e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—atherosclerosis	1.86e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.85e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	1.84e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.84e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—atherosclerosis	1.82e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.82e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	1.82e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	1.82e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.82e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—atherosclerosis	1.81e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—atherosclerosis	1.8e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.8e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	1.8e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—atherosclerosis	1.8e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—atherosclerosis	1.79e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.79e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	1.79e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.79e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	1.79e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NFKB1—atherosclerosis	1.78e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.78e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	1.78e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.78e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—atherosclerosis	1.77e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	1.77e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—atherosclerosis	1.77e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.77e-06	1.59e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.77e-06	1.59e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	1.77e-06	1.59e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	1.76e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.76e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	1.76e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—atherosclerosis	1.75e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK8—atherosclerosis	1.75e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—atherosclerosis	1.75e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	1.75e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.75e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—atherosclerosis	1.75e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	1.75e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	1.74e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	1.74e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—atherosclerosis	1.74e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOB—atherosclerosis	1.74e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	1.74e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	1.73e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	1.73e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.72e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	1.72e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.72e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	1.72e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.72e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	1.71e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—atherosclerosis	1.71e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—atherosclerosis	1.69e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.69e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.69e-06	1.52e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—atherosclerosis	1.68e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—atherosclerosis	1.67e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	1.67e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—atherosclerosis	1.66e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—atherosclerosis	1.66e-06	1.49e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.65e-06	1.49e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.64e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.64e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.63e-06	1.47e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.63e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.62e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—atherosclerosis	1.62e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.62e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—atherosclerosis	1.62e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—atherosclerosis	1.62e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.61e-06	1.45e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.61e-06	1.45e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—atherosclerosis	1.61e-06	1.45e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.61e-06	1.45e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.6e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—atherosclerosis	1.6e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.6e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.6e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—atherosclerosis	1.6e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.59e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.59e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.59e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.59e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.59e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CD36—atherosclerosis	1.58e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.58e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.57e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—atherosclerosis	1.57e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.56e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—atherosclerosis	1.55e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—atherosclerosis	1.55e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.53e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.53e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.53e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.53e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.52e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.51e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—atherosclerosis	1.51e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.51e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.5e-06	1.35e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.5e-06	1.35e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—atherosclerosis	1.49e-06	1.34e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.49e-06	1.34e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.49e-06	1.34e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.48e-06	1.33e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—atherosclerosis	1.48e-06	1.33e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.48e-06	1.33e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.48e-06	1.33e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARA—atherosclerosis	1.47e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.46e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.46e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.46e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.46e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.46e-06	1.31e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—atherosclerosis	1.43e-06	1.29e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGT—atherosclerosis	1.42e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.4e-06	1.26e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—atherosclerosis	1.39e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—atherosclerosis	1.39e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—atherosclerosis	1.39e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAV1—atherosclerosis	1.38e-06	1.24e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOA1—atherosclerosis	1.38e-06	1.24e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—atherosclerosis	1.37e-06	1.24e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—atherosclerosis	1.36e-06	1.22e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.35e-06	1.22e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.35e-06	1.21e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.3e-06	1.17e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.29e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.26e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.26e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—atherosclerosis	1.25e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.24e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.24e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—atherosclerosis	1.23e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—atherosclerosis	1.21e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.2e-06	1.08e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.19e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—atherosclerosis	1.19e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.16e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.14e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—atherosclerosis	1.14e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—atherosclerosis	1.13e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.12e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—atherosclerosis	1.12e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.12e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.11e-06	1e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.1e-06	9.92e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.1e-06	9.9e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—atherosclerosis	1.09e-06	9.83e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.05e-06	9.48e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—atherosclerosis	1.04e-06	9.4e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.04e-06	9.32e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.03e-06	9.3e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—atherosclerosis	1.03e-06	9.3e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.03e-06	9.27e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.03e-06	9.24e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.02e-06	9.19e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.02e-06	9.15e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.01e-06	9.13e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.55e-07	8.6e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	9.42e-07	8.48e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—atherosclerosis	7.79e-07	7.01e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—atherosclerosis	7.34e-07	6.61e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—atherosclerosis	4.8e-07	4.32e-06	CbGpPWpGaD
